Methylglyoxal induces G:C to C:G and G:C to T:A transversions in the supF gene on a shuttle vector plasmid replicated in mammalian cells

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 468, Issue 2, 2000, Pages 173-182

  Murata Kamiya, Naoko ^a   Kamiya, Hiroyuki ^a   Kaji, Hiroshi ^a   Kasai, Hiroshi ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Methylglyoxal; Shuttle vector plasmid pMY189; Simian COS 7 cells

Indexed keywords

METHYLGLYOXAL;

ANIMAL CELL; ARTICLE; CYTOTOXICITY; GENE MUTATION; LIPID PEROXIDATION; MAMMAL CELL; MUTATION; MUTATION RATE; NONHUMAN; PLASMID; PRIORITY JOURNAL; SHUTTLE VECTOR;

ANIMALS; BASE PAIRING; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; COS CELLS; ESCHERICHIA COLI; GENES, SUPPRESSOR; GENETIC VECTORS; MOLECULAR SEQUENCE DATA; MUTAGENICITY TESTS; POINT MUTATION; PYRUVALDEHYDE; SEQUENCE DELETION;

EID: 0034632250     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(00)00044-9     Document Type: Article

References (46)

1. Richard J.P. Mechanism for the formation of methylglyoxal from triosephosphates. Biochem. Soc. Trans. 21:1993;549-553.
2. Phillips S.A., Thornalley P.J. The formation of methylglyoxal from triose phosphates/Investigation using a specific assay for methylglyoxal. Eur. J. Biochem. 212:1993;101-105.
3. Esterbauer H. Aldehydic products of lipid peroxidation. McBrien D.C.H., Slater T.F. Free Radicals, Lipid peroxidation and Cancer. 1982;101-121 Academic Press, New York.
4. Lyles G.A., Chalmers J. The metabolism of aminoacetone to methylglyoxal by semicarbazide-sensitive amine oxidase in human umbilical artery. Biochem. Pharmacol. 43:1992;1409-1414.
5. Reichard G.A. Jr., Skutches C.L., Hoeldtke R.D., Owen O.E. Acetone metabolism in humans during diabetic ketoacidosis. Diabetes. 35:1986;668-674.
6. Chaplen F.W.R., Fahl W.E., Cameron D.C. Detection of methylglyoxal as a degradation product of DNA and nucleic acid components treated with strong acid. Anal. Biochem. 236:1996;262-269.
7. Kasai H., Kumeno K., Yamaizumi Z., Nishimura S., Nagao M., Fujita Y., Sugimura T., Nukaya H., Kosuge T. Mutagenicity of methylglyoxal in coffee. Gann. 73:1982;681-683.
8. Hayashi T., Shibamoto T. Analysis of methyl glyoxal in foods and beverages. J. Agric. Food Chem. 33:1985;1090-1093.
9. Nagao M., Fujita Y., Wakabayashi K., Nukaya H., Kosuge T., Sugimura T. Mutagens in coffee and other beverages. Environ. Health Perspect. 67:1986;89-91.
10. Moree-Testa P., Saint-Jalm Y. Determination of α-dicarbonyl compounds in cigarette smoke. J. Chromatogr. 217:1981;197-208.
11. Lo T.W.C., Westwood M.E., McLellan A.C., Selwood T., Thornalley P.J. Binding and modification of proteins by methylglyoxal under physiological conditions/A kinetic and mechanistic study with Nα-acetylarginine, Nα-acetylcysteine, and Nα-acetyllysine, and bovine serum albumin. J. Biol. Chem. 269:1994;32299-32305.
12. Takahashi K. The reactions of phenylglyoxal and related reagents with amino acids. J. Biochem. (Tokyo). 81:1977;395-402.
13. Takahashi K. Further studies on the reactions of phenylglyoxal and related reagents with proteins. J. Biochem. (Tokyo). 81:1977;403-414.
14. Westwood M.E., McLellan A.C., Thornalley P.J. Receptor-mediated endocytic uptake of methylglyoxal-modified serum albumin/Competition with advanced glycation end product-modified serum albumin at the advanced glycation end product receptor. J. Biol. Chem. 269:1994;32293-32298.
15. 2-alkylguanines. Biochemistry. 8:1969;238-245.
16. Krymkiewicz N. Reactions of methylglyoxal with nucleic acids. FEBS Lett. 29:1973;51-54.
17. 32P-postlabelling method for the analysis of 2′-deoxyguanosine-3′-monophosphate and DNA adducts of methylglyoxal. Carcinogenesis. 15:1994;1887-1894.
18. Bronzetti G., Corsi C., del Chiaro D., Boccardo P., Vellosi R., Rossi F., Paolini M., Cantelli Forti G. Methylglyoxal: genotoxicity studies and its effect in vivo on the hepatic microsomal mono-oxygenase system of the mouse. Mutagenesis. 2:1987;275-277.
19. Perry K.L., Walker G.C. Identification of plasmid (pKM101)-coded proteins involved in mutagenesis and UV resistance. Nature. 300:1982;278-281.
20. Walker G.C. Plasmid (pKM101)-mediated enhancement of repair and mutagenesis: dependence on chromosomal genes in Escherichia coli K-12. Mol. Gen. Genet. 152:1977;93-103.
21. Migliore L., Barale R., Bosco E., Giorgelli F., Minunni M., Scarpato R., Loprieno N. Genotoxicity of methylglyoxal: cytogenetic damage in human lymphocytes in vitro and in intestinal cells of mice. Carcinogenesis. 11:1990;1503-1507.
22. Brambilla G., Sciabà L., Faggin P., Finollo R., Bassi A.M., Ferro M., Marinari U.M. Methylglyoxal-induced DNA-protein cross-links and cytotoxicity in Chinese hamster ovary cells. Carcinogenesis. 6:1985;683-686.
23. Furihata C., Sato Y., Matsushima T., Tatematsu M. Induction of ornithine decarboxylase and DNA synthesis in rat stomach mucosa by methylglyoxal. Carcinogenesis. 6:1985;91-94.
24. Takahashi M., Okamiya H., Furukawa F., Toyoda K., Sato H., Imaida K., Hayashi Y. Effects of glyoxal and methylglyoxal administration on gastric carcinogenesis in Wister rats after initiation with N-methyl-N′-nitro-N-nitrosoguanidine. Carcinogenesis. 10:1989;1925-1927.
25. Brownlee M. Lilly lecture 1993, Glycation and diabetic complications. Diabetes. 43:1994;836-841.
26. Vlassara H., Bucala R., Striker L. Biology of disease. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab. Invest. 70:1994;138-151.
27. McLellan A.C., Phillips S.A., Thornalley P.J. The assay of methylglyoxal in biological systems by derivatization with 1,2-diamino-4,5-dimethoxybenzene. Anal. Biochem. 206:1992;17-23.
28. Beisswenger P.J., Howell S.K., Touchette A.D., Lal S., Szwergold B.S. Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes. 48:1999;198-202.
29. Odani H., Shinzato T., Matsumoto Y., Usami J., Maeda K. Increase in three α,β-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced maillard reaction. Biochem. Biophys. Res. Commun. 256:1999;89-93.
30. Murata-Kamiya N., Kaji H., Kasai H. Deficient nucleotide excision repair increases base-pair substitutions but decreases TGGC frameshifts induced by methylglyoxal in Escherichia coli. Mutat. Res. 442:1999;19-28.
31. Matsuda T., Yagi T., Kawanishi M., Matsui S., Takebe H. Molecular analysis of mutations induced by 2-chloroacetaldehyde, the ultimate carcinogenic form of vinyl chloride, in human cells using shuttle vectors. Carcinogenesis. 16:1995;2389-2394.
32. Akasaka S., Takimoto K., Yamamoto K. G:C→T:A and G:C→C:G transversions are the predominant spontaneous mutations in the Escherichia coli supF gene: an improved lacZ(am) E. coli host designed for assaying pZ189 supF mutational specificity. Mol. Gen. Genet. 235:1992;173-178.
33. Miller J.H. A Short Course in Bacterial Genetics. 1992;Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
34. Stary A., Sarasin A. Simian virus 40 (SV40) large T antigen-dependent amplification of an Epstein-Barr virus-SV40 hybrid shuttle vector integrated into the human HeLa cell genome. J. Gen. Virol. 73:1992;1679-1685.
35. Murata-Kamiya N., Kamiya H., Kaji H., Kasai H. Glyoxal, a major product of DNA oxidation, induces mutations at G:C sites on a shuttle vector plasmid replicated in mammalian cells. Nucleic Acids Res. 25:1997;1897-1902.
36. Rahman A., Shahabuddin, Hadi S.M. Formation of strand breaks and interstrand cross-links in DNA by methylglyoxal. J. Biochem. Toxicol. 5:1990;161-166.
37. Schaaper R.M., Kunkel T.A., Loeb L.A. Infidelity of DNA synthesis associated with bypass of apurinic sites. Proc. Natl. Acad. Sci. U. S. A. 80:1983;487-491.
38. Gentil A., Renault G., Madzak C., Margot A., Cabral-Nato J.B., Vasseur J.J., Rayner B., Imbach J.L., Sarasin A. Mutagenic properties of a unique abasic site in mammalian cells. Biochem. Biophys. Res. Commun. 173:1990;704-710.
39. Kamiya H., Suzuki M., Komatsu Y., Miura H., Kikuchi K., Sakaguchi T., Murata N., Masutani C., Hanaoka F., Ohtsuka E. An abasic site analogue activates a c-Ha-ras gene by a point mutation at modified and adjacent positions. Nucleic Acids Res. 20:1992;4409-4415.
40. Moriya M., Zhang W., Johnson F., Grollman A.P. Mutagenic potency of exocyclic DNA adducts: marked differences between Escherichia coli and simian kidney cells. Proc. Natl. Acad. Sci. U. S. A. 91:1994;11899-11903.
41. Murata-Kamiya N., Kamiya H., Kaji H., Kasai H. Mutational specificity of glyoxal, a product of DNA oxidation, in the lacI gene of wild-type Escherichia coli W3110. Mutat. Res. 377:1997;255-262.
42. Kasai H., Iwamoto-Tanaka N., Fukada S. DNA modifications by the mutagen glyoxal: adduction to G and C, deamination of C and GC and GA cross-linking. Carcinogenesis. 19:1998;1459-1465.
43. Nishiyama T., Hagiwara Y., Hagiwara H., Shibamoto T. Inhibitory effect of 2″-O-glycosyl isovitexin and α-tocopherol on genotoxic glyoxal formation in a lipid peroxidation system. Food Chem. Toxicol. 32:1994;1047-1051.
44. Kasai H., Hayami H., Yamaizumi Z., Saito H., Nishimura S. Detection and identification of mutagens and carcinogens as their adducts with guanosine derivatives. Nucleic Acids Res. 12:1984;2127-2136.
45. Akasaka S., Yamamoto K. Mutagenesis resulting from DNA damage by lipid peroxidation in the supF gene of Escherichia coli. Mutat. Res., DNA Repair. 315:1994;105-112.
46. Valentine M.R., Rodriguez H., Termini J. Mutagenesis by peroxy radical is dominated by transversions at deoxyguanosine: evidence for the lack of involvement of 8-oxo-dG and/or abasic site formation. Biochemistry. 37:1998;7030-7038.